Cart
sales@molnova.com
Exo1
CAS No. 75541-83-2
Exo1 ( Exo-1; Exo 1; Exo1 )
Catalog No. M19078 CAS No. 75541-83-2
Exo1 is a chemical inhibitor of the exocytic pathway.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 39 | In Stock |
|
| 50MG | 143 | In Stock |
|
| 100MG | 215 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameExo1
-
NoteResearch use only, not for human use.
-
Brief DescriptionExo1 is a chemical inhibitor of the exocytic pathway.
-
DescriptionExo-1 is a reversible inhibitor of exocytosis, activating Golgi ARF 1 (ADP-Ribosylation Factor) GTPase..
-
SynonymsExo-1; Exo 1; Exo1
-
PathwayOthers
-
TargetOther Targets
-
Recptorothers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number75541-83-2
-
Formula Weight273.26
-
Molecular FormulaC15H12FNO3
-
Purity98%
-
SolubilityDMSO : 25 mg/mL 91.49 mM; H2O : < 0.1 mg/mL
-
SMILESCOC(=O)c1ccccc1NC(=O)c1ccc(F)cc1
-
Chemical Name2-(4-Fluorobenzoylamino)benzoic acid methyl ester
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Feng Y, et al. Exo1: a new chemical inhibitor of the exocytic pathway. Proc Natl Acad Sci U S A. 2003 May 27;100(11):6469-74.
molnova catalog
related products
-
Linzagolix
Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis.
-
ICCB-19 HCl（750621-5...
ICCB-19 HCl is an inhibitor of TRADD (TNFRSF1A Associated Via Death Domain).
-
Strontium chloride
Strontium chloride is an agonist of Calcium sensing receptor (CaSR) and directly affects C-type nerve fibers.
